MicroTech Medical (Hangzhou) Co (HKSE:02235) Beta : N/A (As of May. 24, 2024)

View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-24), MicroTech Medical (Hangzhou) Co's Beta is Not available.

MicroTech Medical (Hangzhou) Co Beta Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Beta Chart

MicroTech Medical (Hangzhou) Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Beta

MicroTech Medical (Hangzhou) Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beta	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of MicroTech Medical (Hangzhou) Co's Beta

For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroTech Medical (Hangzhou) Co's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's Beta distribution charts can be found below:

* The bar in red indicates where MicroTech Medical (Hangzhou) Co's Beta falls into.

MicroTech Medical (Hangzhou) Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

MicroTech Medical (Hangzhou) Co Beta Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Beta

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.microtechmd.com

MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.

Executives

Zheng Pan
Master Summer Limited	2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd	2201 Interest of corporation controlled by you
Cdbi Partners Fund Ii, L.p.	2201 Interest of corporation controlled by you
Cdbi Partners Fund I, L.p.	2201 Interest of corporation controlled by you
Cdbi Gp, Ltd	2201 Interest of corporation controlled by you
Cd Capital Healthcare Fund V, L.p.	2201 Interest of corporation controlled by you
Cd Capital Gp Ltd	2201 Interest of corporation controlled by you
Zhe Jiang Jiu Ren Zi Ben Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp V, L.p.	2201 Interest of corporation controlled by you
Qiming Venture Partners V, L.p.	2201 Interest of corporation controlled by you
Qm32 Limited	2101 Beneficial owner
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Lav Evergreen (hong Kong) Co., Limited	2101 Beneficial owner

MicroTech Medical (Hangzhou) Co (HKSE:02235) Headlines

No Headlines